Ondansetron Hydrochloride Tablet, Film Coated
Product Images NDC 57237-075

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Ondansetron Hydrochloride (NDC 57237-075). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rising Pharma Holdings, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (4 mg (30 Tablet Bottle))

This is a description for Ondansetron hydrochloride USP tablets. Each film-coated tablet contains 4 mg of ondansetron hydrochloride dihydrate. The tablets are distributed by Rising Health, LLC and come in a container defined by the USP. The recommended mode of administration is available for dosage and administration. The tablets should be stored at 20° to 25°C (68° to 77°F) with excursions that are permitted to 15°-30°C (59-86°F). The text also includes a code- TS/IDRUGS/19/1993 and a National Drug Code (NDC) 57237 075 30.*

FDA Label Image

Package Label-principal Display Panel (8 mg (30 Tablet Bottle))

This is a medication from Rising Health LLC called Ondansetron. It is a tablet medication that comes in a package with 30 tablets. The usual dosage instructions can be found on the package. It should be kept in a light-resistant container at controlled room temperatures. This medication should be protected from light.*

FDA Label Image

Chemical Structure (Ondansetron Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.